Research Overview: Prosoma
Prosoma 500mg Carisoprodol is a centrally-acting muscle relaxant belonging to the carbamate class of compounds, manufactured by Centurion Laboratories for research applications. This compound operates through modulation of gamma-aminobutyric acid (GABA) receptors and exhibits complex pharmacological properties that make it valuable for laboratory investigations. Researchers studying muscle physiology, neuromuscular function, and central nervous system mechanisms frequently examine carisoprodol’s unique dual-action profile, which involves both direct GABA receptor interaction and metabolic conversion to meprobamate. The compound’s rapid onset and distinctive pharmacokinetic profile provide researchers with a well-characterised model for investigating muscle relaxation pathways and neurotransmitter modulation in controlled laboratory environments.
Research Applications
Laboratory studies investigate carisoprodol’s mechanism of action through GABA receptor binding assays and neurotransmitter release experiments. Research teams examine the compound’s ability to modulate chloride ion channels and its effects on synaptic transmission in neural tissue preparations. The metabolic conversion to meprobamate creates additional research opportunities for studying compound biotransformation and secondary pharmacological activities. Researchers at Stroid UK Shop evaluate carisoprodol’s interactions with various receptor systems beyond GABA, including potential effects on voltage-gated sodium channels. Studies often compare carisoprodol’s activity profile with other muscle relaxants to understand structure-activity relationships within this therapeutic class. Neuropharmacology research utilises this compound to investigate central nervous system depression mechanisms and receptor selectivity patterns. The compound’s relatively short duration of action makes it particularly suitable for acute experimental protocols examining rapid-onset muscle relaxation phenomena. Research teams studying carisoprodol and related compounds often investigate its potential for tolerance development and receptor desensitisation studies. Additionally, comparative research with selective androgen receptor modulators explores different approaches to muscle function modulation, while studies alongside peptide research compounds examine complementary mechanisms in neuromuscular research protocols.
Technical Specifications
| Active Compound | Carisoprodol |
|---|---|
| Concentration | 500mg per tablet |
| Manufacturer | Centurion Laboratories |
| Chemical Formula | C₁₂H₂₄N₂O₄ |
| Molecular Weight | 260.33 g/mol |
| CAS Number | 78-44-4 |
| Storage Requirements | Room temperature, dry environment |
| Solubility | Water-soluble |
Research Compliance
This product is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical use, or any therapeutic purposes. Researchers must ensure proper laboratory safety protocols and appropriate disposal methods when conducting studies with this compound. All research activities should comply with applicable institutional guidelines and regulatory requirements for laboratory chemical handling.
